Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Non-Current Assets (2016 - 2017)

Bone Biologics has reported Non-Current Assets over the past 3 years, most recently at $146.0 for Q4 2017.

  • Quarterly Non-Current Assets fell 39.67% to $146.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $728.0 through Dec 2017, down 39.74% year-over-year, with the annual reading at $146.0 for FY2017, 39.67% down from the prior year.
  • Non-Current Assets was $146.0 for Q4 2017 at Bone Biologics, down from $170.0 in the prior quarter.
  • Over five years, Non-Current Assets peaked at $5804.0 in Q4 2015 and troughed at $146.0 in Q4 2017.
  • The 3-year median for Non-Current Assets is $242.0 (2016), against an average of $860.0.
  • Year-over-year, Non-Current Assets plummeted 95.83% in 2016 and then crashed 39.67% in 2017.
  • A 3-year view of Non-Current Assets shows it stood at $5804.0 in 2015, then plummeted by 95.83% to $242.0 in 2016, then crashed by 39.67% to $146.0 in 2017.
  • Per Business Quant, the three most recent readings for BBLG's Non-Current Assets are $146.0 (Q4 2017), $170.0 (Q3 2017), and $194.0 (Q2 2017).